LOS ANGELES, CA / ACCESSWIRE / November 30, 2016 / Exactus, Inc. (OTCQB: EXDI) announced today that it will be presenting at the 9th annual LD Micro Main Event on Wednesday, December 7 at 1:00 PM PST / 4:00 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Philip Young, CEO and Chairman of Exactus Inc., will be presenting, as well as meeting with investors.
The LD Micro Main Event is the largest independent conference for small/microcap companies and will feature 240 presenting names.
View Exactus' profile here: http://www.ldmicro.com/profile/EXDI
News Compliments of Accesswire.
About Exactus, Inc.
Exactus, Inc. (OTCQB: EXDI) is a publicly traded, multinational Medical Device company that is developing handheld Point of Care devices for use in coagulation and cancer diagnostics. We are changing the way physicians are able to access vital clinical data. We will replace central laboratory and tabletop lab tests that currently take 20 minutes to several hours by delivering the critical information in 30 seconds. Our lead device, the FibriLyzer™, measures fibrinolysis, a key component in hemostasis and documented contributor of mortality in many hospital settings. Exactus is also developing the MatriLyzer™, which will provide monitoring for tumor recurrence or metastasis in cancer patients potentially allowing for earlier detection and treatment.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into an event platform hosting several influential conferences annually (Invitational, Summit, and Main Event).
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector. LD will continue to provide valuable tools for the benefit of everyone in the small and microcap universe.
SOURCE: Exactus, Inc. via LD Micro
Released November 30, 2016